Last updated: 02/03/2020 18:40:06

A Clinical Study to Evaluate Potential Biomarkers in Osteoarthritis Patients

GSK study ID
114261
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A Clinical Study to Evaluate Potential Biomarkers in Osteoarthritis Patients
Trial description: A Clinical Study to Evaluate Potential Biomarkers in Osteoarthritis Patients
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
92
Primary completion date:
2011-22-11
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Graham N, Boyle Y, Larkin J, Liu F, Peters G, Saunders J, Sully K, Whittall C, Cooper L, Matheny C, Germaschewski F.A Clinical Study to Evaluate Potential Biomarkers in Osteoarthritis Patients.Osteoarthr Cartil.2014;
Medical condition
Osteoarthritis
Product
Not applicable
Collaborators
Not applicable
Study date(s)
March 2011 to November 2011
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Cambridge, United Kingdom, CB2 2GG
Status
Study Complete
Location
GSK Investigational Site
Oswestry, Shropshire, United Kingdom, SY 10 7AG
Status
Study Complete

Study documents

Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Study complete
Actual primary completion date
2011-22-11
Actual study completion date
2011-22-11

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website